 We investigated risk factors for the development of mixed chimerism in 131 patients who underwent transplantation for myelofibrosis and determined the impact of lymphoid and myeloid chimerism on transplant outcome . Disease risk included DIPSS plus categories low to high . The median patient age was 58 years . Patients were conditioned with high intensity or low reduced intensity regimens and received a transplant from a related or unrelated donor . Mixed CD3

@highlight Mixed CD3
@highlight chimerism is associated with reduced grafter versus host disease and improved relapse free survival.
@highlight Mixed CD33
@highlight chimerism is associated with increased incidence of relapse.
@highlight Mixed CD3
@highlight chimerism is not associated with risk of graft rejection.
